The precision cancer diagnostics firm Epredia will distribute Mindpeak's AI-based image recognition solutions for clinical diagnostics, research, and pharma development.
The interferon-gamma release assay for latent tuberculosis infection is designed for use on Diasorin's automated, high-throughput Liaison XL platform.
Last week, readers were most interested in a story about a deal between QuidelOrtho and Shenzhen Lifotronic Technology covering immunoassays.
Labcorp said it will be using the company's FDA-cleared AISight Dx platform across its national network of anatomic pathology labs and hospital collaborations.
The transition from testing the dead to testing the living is the latest example of how genomics is expanding horizons for ...
The company plans to begin using the instrument in its Burlington, North Carolina, lab in the first quarter of the year and ...
The cleared assays included point-of-care and home tests for infectious and chronic diseases and drugs of abuse.
NEW YORK — Hardy Diagnostics said on Wednesday that two of its immunoassays for drug-resistant pathogen detection have been designated breakthrough devices by the US Food and Drug Administration. Both ...
The test runs on the company's OneBreath platform and is designed to assess a patient's risk for postoperative pneumonia.
The agreement pertains to multiple immunoassay analyzers and test menus that QuidelOrtho expects will increase its competitiveness in international tenders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results